Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: The European Epoetin Alfa Surgery Trial (EEST)

European Journal of Anaesthesiology

Volumn 22, Issue 4, 2005, Pages 249-257

  Weber, E W G ^a,i   Slappendel, Robert ^a   Hemon Y ^b   Mahler S ^c   Dalen T ^d   Rouwet, E ^e   Van Os, J ^f   Vosmaer, A ^g   Van Der Ark, P ^h  

^a SINT MAARTENSKLINIEK   (Netherlands)

^b HÔPITAL SAINTE MARGUERITE   (France)

^c Kreiskrankenhaus ^*  (Germany)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^e MEDISCH SPECTRUM TWENTE   (Netherlands)

^f Sittard Geleen Heerlen   (Netherlands)

^g IKAZIA HOSPITAL   (Netherlands)

^h ENVIRON Netherlands BV   (Netherlands)

ⁱ CATHARINA HOSPITAL   (Netherlands)

Author keywords

Arthroplasty replacement hip, arthroplasty replacement knee; Blood transfusion, autologous, allogeneic; Erythropoietin, recombinant, epoetin alfa; Haemoglobin; Hospitalization, length of stay; Surgical wound infection

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFECT; DRUG SAFETY; FEMALE; GENERAL ANESTHESIA; HEMOGLOBIN DETERMINATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; KNEE ARTHROPLASTY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; MULTICENTER STUDY; ORTHOPEDIC SURGERY; OUTCOMES RESEARCH; PHASE 4 CLINICAL TRIAL; POSTOPERATIVE INFECTION; RANDOMIZED CONTROLLED TRIAL; SPINAL ANESTHESIA; SURGICAL INFECTION; THROMBOSIS; TOTAL HIP PROSTHESIS;

AGED; ANEMIA; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION; EPOETIN ALFA; EUROPE; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; MALE; ORTHOPEDIC PROCEDURES; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 19544370208     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0265021505000426     Document Type: Article

References (24)

1. Rosencher N, Kerkkamp H, Macheras G, et al. Orthopedic surgery transfusion hemoglobin European overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43: 459-469.
2. Marquet RL, Hoynck van Papendrecht MA, Busch OR, Jeekel J. Blood donation leads to a decrease in natural killer cell activity: a study in normal blood donors and cancer patients. Transfusion 1993; 33: 368-373.
3. Landers DF, Hill GE, Wong KC, Fox IJ. Blood transfusion-induced immunomodulation. Anesth Analg 1996; 82: 187-204.
4. Innerhofer P, Luz G, Spotl L, et al. Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus white cell-reduced blood to patients undergoing arthroplasty. I. Proliferative T-cell responses and the balance of helper and suppressor T cells. Transfusion 1999; 39: 1089-1096.
5. Spahn DR. Eliminating blood transfusions. New aspects and perspectives. Anesthesiology 2000; 93: 242-255.
6. Slappendel R, Weber EWG. Blood transfusions and postoperative recovery in orthopaedic surgery. The European Eprex surgery trial. Transfusion Alternatives in Transfusion Medicine 2004; 6 (1): 24-28.
7. Goldberg MA, McCutchen JW, Jove M, et al. A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 1996; 25: 544-552.
8. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81-A: 2-10.
9. Adamson J. Perisurgical use of epoetin alfa in orthopedic surgery patients. Semin Hematol 1996; 33: 55-58.
10. De Andrade JR, Jove M, Landon G, Frei D, Guilfoyle M, Young DC. Baseline hemoglobin as a predictor of risk of transfusion and response to epoetin alfa in orthopedic surgery patients. Am J Orthop 1996; 25: 533-542.
11. Olijhoek G, Megens JG, Musto P, et al. Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo-controlled trial. Transfusion 2001; 41: 957-963.
12. Slappendel R, Dirksen R, Weber EWG, Van der Schaaf DB. An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery. Acta Orthop Scand 2003; 74: 569-575.
13. Feagan BG, Wong CJ, Kirkley A, et al. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. Ann Intern Med 2000; 133: 845-854.
14. Van Iperen CE, Kraaijenhagen RJ, Biesma DH, Beguin Y, Marx JJ, van de Wiel An. Iron metabolism and erythropoiesis after surgery. Br J Surg 1998; 85: 41-45.
15. Weber EWG, Slappendel R, Prins MH, Van der Schaaf DB, Durieux ME. Peroperative blood transfusions and delayed wound healing after hip replacement surgery: effects on hospitalisation. Chapter 5 in Thesis of EWG Weber, Maastricht University, The Netherlands, 2003.
16. Blumberg N. Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol 1997; 34: 34-40.
17. Houbiers JG, Van de Velde CJ, Van de Watering LM, et al. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion 1997; 37: 126-134.
18. Vamvakas EC, Carven JH. Allogeneic blood transfusion, hospital charges, and length of hospitalization. A study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med 1998; 122: 145-151.
19. Carson JL, Altman DG, Duff A, et al. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999; 39: 694-700.
20. Innerhofer P, Walleczek C, Luz G, et al. Transfusion of buffy coat-depleted blood components and risk of postoperative infection in orthopedic patients. Transfusion 1999; 39: 625-632.
21. Sonnenberg FA, Gregory P, Yomtovian R, et al. The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterial infection with allogeneic transfusion. Transfusion 1999; 39: 808-817.
22. Brandi LS, Oleggini M, Lachi S, et al. Energy metabolism of surgical patients in the early postoperative period: a reappraisal. Crit Care Med 1988; 16: 18-22.
23. Brandi LS, Bertolini R, Janni A, Gioia A, Angeletti CA. Energy metabolism of thoracic surgery surgical patients in the early post operative period. Chest 1996; 109: 630-637.
24. Buick FJ, Gledhill N, Froese AB, Spriet L, Meyers EC. Effect of induced erythrocythemia on aerobic work capacity. J Appl Physiol 1980; 48: 636-642.